Events

Back

Coolerr Bags Information

August 15th 2019

Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure. Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure. Promethera Biosciences SA, a global innovator in cell-based medicines and liver diseases, announced that clinical data from the ongoing phase 2a study of its lead product candidate HepaStem ® in patients with Acute-on-Chronic Liver Failure.

15.08.2019 / 12:00 > 4:00 PM 58 Greta Street

FIND MORE INFO & REGISTER HERE